fair enough. CytoDyn’s First mTNBC Patient i
Post# of 148186
(Total Views: 533)
Posted On: 03/12/2020 12:33:12 PM
Re: craigakess #21213
fair enough.
CytoDyn’s First mTNBC Patient in Phase 1b/2 is in Remission and Oncologist Ordered Termination of Treatment with Carboplatin (chemotherapy drug) and Remains on Leronlimab Only as Monotherapy; Patient’s Testimony about Her Condition After Nearly 6 Months of Leronlimab Treatment is Very Strong
CytoDyn’s First mTNBC Patient in Phase 1b/2 is in Remission and Oncologist Ordered Termination of Treatment with Carboplatin (chemotherapy drug) and Remains on Leronlimab Only as Monotherapy; Patient’s Testimony about Her Condition After Nearly 6 Months of Leronlimab Treatment is Very Strong
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼